Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in recognition of her research into how tumor microenvironments impact cancer ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

New research shows a common skin fungus can help melanoma spread by changing cancer cell movement and energy use.

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment.

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...

Researchers say cancer's ability to evade treatment and recur is partly due to tumor cells switching between states to ...

Please provide your email address to receive an email when new articles are posted on . Tucatinib plus maintenance therapy with trastuzumab and pertuzumab delayed metastatic breast cancer progression.

But an association with improved overall survival failed to reach statistical significance ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...